Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEMOLIZUMAB vs NERATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NEMOLIZUMAB vs NERATINIB: Safety Overview

Metric NEMOLIZUMAB NERATINIB
Total FAERS Reports 371 2,089
Deaths Reported 54 327
Death Rate 14.6% 15.7%
Hospitalizations 136 609
Average Patient Age 63.9 yrs 58.1 yrs
% Female Patients 37.5% 98.8%
FDA Approval Date N/A Jul 17, 2017
Manufacturer Galderma Laboratories, L.P. N/A
Route SUBCUTANEOUS N/A
Marketing Status N/A Prescription